BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 30016717)

  • 21. Characterization and identification of protein O-GlcNAcylation sites with substrate specificity.
    Wu HY; Lu CT; Kao HJ; Chen YJ; Chen YJ; Lee TY
    BMC Bioinformatics; 2014; 15 Suppl 16(Suppl 16):S1. PubMed ID: 25521204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse.
    Trinidad JC; Barkan DT; Gulledge BF; Thalhammer A; Sali A; Schoepfer R; Burlingame AL
    Mol Cell Proteomics; 2012 Aug; 11(8):215-29. PubMed ID: 22645316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and identification of O-GlcNAc-modified peptides using phosphate-based alkyne CLICK chemistry in combination with titanium dioxide chromatography and mass spectrometry.
    Parker BL; Gupta P; Cordwell SJ; Larsen MR; Palmisano G
    J Proteome Res; 2011 Apr; 10(4):1449-58. PubMed ID: 21158410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory-associated proteins in Alzheimer's disease.
    Wang S; Yang F; Petyuk VA; Shukla AK; Monroe ME; Gritsenko MA; Rodland KD; Smith RD; Qian WJ; Gong CX; Liu T
    J Pathol; 2017 Sep; 243(1):78-88. PubMed ID: 28657654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory O-GlcNAcylation sites on FoxO1 are yet to be identified.
    Fardini Y; Perez-Cervera Y; Camoin L; Pagesy P; Lefebvre T; Issad T
    Biochem Biophys Res Commun; 2015 Jun; 462(2):151-8. PubMed ID: 25944660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Terminal differentiation program of skeletal myogenesis is negatively regulated by O-GlcNAc glycosylation.
    Ogawa M; Mizofuchi H; Kobayashi Y; Tsuzuki G; Yamamoto M; Wada S; Kamemura K
    Biochim Biophys Acta; 2012 Jan; 1820(1):24-32. PubMed ID: 22056510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical Reporters and Their Bioorthogonal Reactions for Labeling Protein
    Kim EJ
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30241321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping of O-linked beta-N-acetylglucosamine modification sites in key contractile proteins of rat skeletal muscle.
    Hédou J; Bastide B; Page A; Michalski JC; Morelle W
    Proteomics; 2009 Apr; 9(8):2139-48. PubMed ID: 19322778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of O-GlcNAcylation in the Skeletal Muscle Physiology and Physiopathology: Focus on Muscle Metabolism.
    Lambert M; Bastide B; Cieniewski-Bernard C
    Front Endocrinol (Lausanne); 2018; 9():578. PubMed ID: 30459708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying potentially O-GlcNAcylated proteins using metabolic labeling, bioorthogonal enrichment, and Western blotting.
    Darabedian N; Pratt MR
    Methods Enzymol; 2019; 622():293-307. PubMed ID: 31155058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative Profiling of Protein O-GlcNAcylation Sites by an Isotope-Tagged Cleavable Linker.
    Qin K; Zhu Y; Qin W; Gao J; Shao X; Wang YL; Zhou W; Wang C; Chen X
    ACS Chem Biol; 2018 Aug; 13(8):1983-1989. PubMed ID: 30059200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing O-GlcNAcylation level on organ culture of soleus modulates the calcium activation parameters of muscle fibers.
    Cieniewski-Bernard C; Montel V; Berthoin S; Bastide B
    PLoS One; 2012; 7(10):e48218. PubMed ID: 23110217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical arsenal for the study of O-GlcNAc.
    Kim EJ
    Molecules; 2011 Feb; 16(3):1987-2022. PubMed ID: 21358590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple reaction monitoring mass spectrometry for the discovery and quantification of O-GlcNAc-modified proteins.
    Maury JJ; Ng D; Bi X; Bardor M; Choo AB
    Anal Chem; 2014 Jan; 86(1):395-402. PubMed ID: 24144119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An OGA-Resistant Probe Allows Specific Visualization and Accurate Identification of O-GlcNAc-Modified Proteins in Cells.
    Li J; Wang J; Wen L; Zhu H; Li S; Huang K; Jiang K; Li X; Ma C; Qu J; Parameswaran A; Song J; Zhao W; Wang PG
    ACS Chem Biol; 2016 Nov; 11(11):3002-3006. PubMed ID: 27622469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detecting and Imaging O-GlcNAc Sites Using Glycosyltransferases: A Systematic Approach to Study O-GlcNAc.
    Wu ZL; Tatge TJ; Grill AE; Zou Y
    Cell Chem Biol; 2018 Nov; 25(11):1428-1435.e3. PubMed ID: 30100348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined Antibody/Lectin Enrichment Identifies Extensive Changes in the O-GlcNAc Sub-proteome upon Oxidative Stress.
    Lee A; Miller D; Henry R; Paruchuri VD; O'Meally RN; Boronina T; Cole RN; Zachara NE
    J Proteome Res; 2016 Dec; 15(12):4318-4336. PubMed ID: 27669760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Detection of O-GlcNAcylated proteins in the heart using antibodies.
    Narayanan B; Zahra F; Reeves RA; Aggarwal A; O'Meally RN; Henry RK; Craven M; Jacobson A; Cole RN; Kohr MJ; Umapathi P; Zachara NE
    Anal Biochem; 2023 Oct; 678():115262. PubMed ID: 37507081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and confirmation of O-GlcNAcylated proteins in rat liver mitochondria by combination of mass spectrometry and immunological methods.
    Cao W; Cao J; Huang J; Yao J; Yan G; Xu H; Yang P
    PLoS One; 2013; 8(10):e76399. PubMed ID: 24098488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new tandem enrichment strategy for the simultaneous profiling of
    Fan Z; Li J; Liu T; Zhang Z; Qin W; Qian X
    Analyst; 2021 Feb; 146(4):1188-1197. PubMed ID: 33465208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.